Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 500 entries
View as:

Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)

Phase: N/A Priority: Normal
NCT ID: NCT00832455 Org: User:
Start: 06/30/06 End: 10/31/08 Due: 10/31/09

Evaluation of the LDL-C Lowering Effects of Ezetimibe Achieved in Co-administration Therapy With Statins in an Indonesian Population (Study P04276)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00705081 Org: User:
Start: 01/31/06 End: 12/31/07 Due: 12/31/08

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)

Phase: N/A Priority: Normal
NCT ID: NCT00702234 Org: User:
Start: 02/15/07 End: 01/15/10 Due: 01/15/11

Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients (Study P05647)

Phase: N/A Priority: Normal
NCT ID: NCT00909389 Org: User:
Start: 11/30/06 End: 11/30/08 Due: 11/30/09

Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00090168 Org: User:
Start: 01/27/04 End: 11/10/04 Due: 11/10/05

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00092768 Org: User:
Start: 03/01/04 End: 02/01/05 Due: 02/01/06

Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)

Phase: N/A Priority: Normal
NCT ID: NCT01656434 Org: User:
Start: 11/02/12 End: 02/12/14 Due: 02/12/15

Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)

Phase: N/A Priority: Normal
NCT ID: NCT00092092 Org: User:
Start: 10/31/02 End: 06/30/04 Due: 06/30/05

An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00092638 Org: User:
Start: 05/31/03 End: 08/31/04 Due: 08/31/05

Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)

Phase: N/A Priority: Normal
NCT ID: NCT00867165 Org: User:
Start: 05/21/09 End: 04/13/12 Due: 04/13/13

A Multicenter Trial to Evaluate the Insertion Characteristics of the Radiopaque Etonogestrel Implant Using a Next Generation Applicator (34530)(P05702)

Phase: N/A Priority: Normal
NCT ID: NCT00620035 Org: User:
Start: 03/31/07 End: 10/31/10 Due: 10/31/11

Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)

Phase: N/A Priority: Normal
NCT ID: NCT00794248 Org: User:
Start: 11/30/02 End: 05/31/03 Due: 05/31/04

Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)

Phase: N/A Priority: Normal
NCT ID: NCT00953680 Org: User:
Start: 04/30/04 End: 07/31/04 Due: 07/31/05

To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia (0733-264)

Phase: N/A Priority: Normal
NCT ID: NCT00398294 Org: User:
Start: 05/01/05 End: 04/04/06 Due: 04/04/07

A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937)

Phase: N/A Priority: Normal
NCT ID: NCT01101464 Org: User:
Start: 10/31/02 End: 12/31/02 Due: 12/31/03

Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113)

Phase: N/A Priority: Normal
NCT ID: NCT00757627 Org: User:
Start: 12/31/07 End: 12/31/08 Due: 12/31/09

A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)

Phase: N/A Priority: Normal
NCT ID: NCT00546052 Org: User:
Start: 09/01/05 End: 01/01/08 Due: 01/01/09

12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)

Phase: N/A Priority: Normal
NCT ID: NCT00145470 Org: User:
Start: 06/02/05 End: 03/22/07 Due: 03/22/08

A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)

Phase: N/A Priority: Normal
NCT ID: NCT00711607 Org: User:
Start: 05/01/07 End: 09/01/07 Due: 09/01/08

A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)

Phase: N/A Priority: Normal
NCT ID: NCT03882996 Org: User:
Start: 10/06/00 End: 02/04/03 Due: 02/04/04

The Effects of Phenylephrine Compared With Those of Placebo and Pseudoephedrine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis (SAR)(P04579)

Phase: N/A Priority: Normal
NCT ID: NCT00276016 Org: User:
Start: 01/31/06 End: 02/28/06 Due: 02/28/07

Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)

Phase: N/A Priority: Normal
NCT ID: NCT03882047 Org: User:
Start: 08/11/94 End: 09/16/94 Due: 09/16/95

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

Phase: N/A Priority: Normal
NCT ID: NCT00095017 Org: User:
Start: 11/30/04 End: - Due: -

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)

Phase: N/A Priority: Normal
NCT ID: NCT00653796 Org: User:
Start: 09/01/03 End: 08/01/04 Due: 08/01/05

Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366)

Phase: N/A Priority: Normal
NCT ID: NCT01368185 Org: User:
Start: 11/30/08 End: 08/31/10 Due: 08/31/11